Therapeutic Solutions International Inc (TSOI)

[biotech18]

ADVFN curncman - Mr. Dixon's reply to your questions:


1) In Mr.Dixon's post on facebook yesterday, he showed the liquid for of TQ and possibly quadrammune in future. If the Quadrammune liquid is ready by summer, will the results be better than taking QUADRAMMUNE in capsule form ?

2) If phase-II trial is successful then will TSOI will be the first biotech/pharma company to bring to patient table via RTT pathway in less thank 1 year time from the time the IND was filed?

3) Is Mr.Dixon open to BUYOUT offer from BS PHARMA? LOL

Mr Dixon's reply:

Next had to do with liquid thymoquinone or TQ as the poser asked. Ok, so here's the deal. The liquid version of QuadraMune (code name Ultra), as in QuadraMune Ultra, of which the liquid TQ is one of the four is designed to be the booster and will be taken for 14 days, followed by regular QuadraMune as maintenance. The liquid is the supercharger - so it's not so much that it is superior to QuadraMune because it's not designed for the long term. You take ultra for 14 days and your immune system is in its most vigilant state it could be in. So I am never satisfied with the final products until we have done some preliminary lab work on them, but one thing about liquids is they are always more bioavailable. These hospital workers are exhausted, their immune system under constant assault - I wanted something to set the record straight if you will, get them primed, immune vigilant, and give them a fighting chance. So we'll be releasing more on that coming up.


His 2nd Q had to do with future clinical work. If we have a proof positive Phase 2 we will have a big powwow with the team and I will make my decision based on their vital input. It would be rare for me to go against their recommendations one way or the other, but ask yourself; would you move to Phase 3 or be happy and go to market - I go P3. RTT could play a role, but one step at a time.


And finally, would we be open to buyout - I suppose. I'm pretty happy with my job LOL and I really like what I'm doing, but a large enough pile of cash - sure - and I'll start brand new biotech and fill it with cutting edge technology . Of course its very easy to get pie-in-the-sky so take everything I say in the spirit it is offered - its 4:30 am. I think of Kite, a handful of guys with a microscope and Phase 1 safety data that was really good. Gilead swooped in and bought them for $12 Billion CASH. If I go to the post office from TSOI HQ, one block away, at the corner is "Kite Pharmaceutical, A Gilead Company".
Those boys didn't say no. We likely wouldn't say no. But tender offers below a dollar are not worth my time or attention. I won't even talk to you. If you are to bring it, then bring it. Otherwise, we will be happy with massive revenues from sales. Pharma would take our compounds and turn them into pharmaceuticals - except one little problem - patents. A bunch of them. They have to buy it all.


I like how Mr. Dixon thinks, would not even think of taking an offer less then a buck.....